SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Ibuprofen May Improve Liver-Related Brain Deficits
August 16, 2007
 · 
1 min read
Drug Development
Abortion Pill Poses No Risk for Later Pregnancy
August 16, 2007
 · 
1 min read
Drug Development
New Review Suggests Caution on Drugs to Raise “Good” Cholesterol
August 15, 2007
 · 
1 min read
Drug Development
University of Pennsylvania School of Medicine Researchers Find Diabetes Drug Kills Some Cancer Cells
August 15, 2007
 · 
1 min read
Drug Development
Merck & Co., Inc. (Jobs)'s Gardasil Aimed at Older Women
August 15, 2007
 · 
1 min read
Drug Development
Alzheimer’s Drugs ‘Help Glaucoma’
August 7, 2007
 · 
1 min read
Drug Development
Georgia Reproductive Specialists Participates In Largest-Ever In Vitro Fertilization Clinical Trial In The World
August 3, 2007
 · 
1 min read
Drug Development
New Two-Drug Kidney Cancer Treatment Found by Duke University Researchers
August 1, 2007
 · 
1 min read
Drug Development
Discovery about Obesity Drug Helping Scientists Develop New Cancer Treatments, Wake Forest University Baptist Medical Center Study
July 27, 2007
 · 
1 min read
Drug Development
Older is Better -- Top-10 Comparison of Diabetes Drugs Give Metformin Top Grade, Johns Hopkins University School of Medicine Study
July 26, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
UCB, Inc. New Oral Solution Formulation of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V)
June 14, 2010
 · 
4 min read
Drug Development
Boehringer Ingelheim Corporation Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
June 14, 2010
 · 
5 min read
Drug Development
Boehringer Ingelheim Corporation affirms safety of telmisartan with an analysis of 50,000 patients and strongly disagrees with the publication of Sipahi et al in Lancet Oncology June 2010
June 14, 2010
 · 
1 min read
Drug Development
SDI Reports: Approximately Half of Patients Prescribed the Most Popular Osteoporosis Drugs Discontinue Therapy within 6 Months
June 14, 2010
 · 
1 min read
Drug Development
FDA Looking Into Death Risk From Daiichi Sankyo, Inc.'s Benicor
June 11, 2010
 · 
1 min read
Drug Development
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Dabigatran Etexilate as Effective and Safe as Enoxaparin in Preventing Venous Thromboembolism (VTE) After Total Hip Replacement Surgery and Significantly Reduced the Combined Endpoint of Major VTE and VT
June 11, 2010
 · 
1 min read
Drug Development
Onset Therapeutics Release: BENZEFOAM(TM) Emollient Foam More Effective in Reducing P. acnes Bacteria Than Prescription Benzoyl Peroxide Cleanser
June 9, 2010
 · 
1 min read
Drug Development
Auxilium Pharmaceuticals Announces Two Year Recurrence Rate of 19.3% for Joints Treated With XIAFLEX(R)
June 8, 2010
 · 
10 min read
Drug Development
Abraxis BioScience, Inc. Release: Among the Toughest Cancers to Treat, New ABRAXANE(R) Data Demonstrates Potential in Patients with Advanced and Malignant Melanoma
June 8, 2010
 · 
1 min read
Drug Development
Celgene International Sárl Release: Evaluation of REVLIMID(R) in Patients with Either GCB or Non-GCB Diffuse Large B-Cell Lymphoma Presented at American Society of Clinical Oncology
June 7, 2010
 · 
1 min read
Drug Development
Celgene Corporation Release: Data from Study of Revlimid(R) in Untreated Patients with Chronic Lymphocytic Leukemia (CLL) Presented at American Society of Clinical Oncology
June 7, 2010
 · 
1 min read
Drug Development
Bristol-Myers Squibb Company Release: Four-Year Follow-Up Data for SPRYCEL(R) (dasatinib) Demonstrate 82 Percent Overall Survival in Patients with Chronic Myeloid Leukemia Who Failed Gleevec(R)
June 7, 2010
 · 
1 min read
Drug Development
Millennium: The Takeda Oncology Company Release: VELCADE(R) (bortezomib) Data in Relapsed or Refractory Amyloidosis Presented at American Society of Clinical Oncology Annual Meeting
June 7, 2010
 · 
1 min read
Drug Development
Abraxis BioScience, Inc. Release: Results of Phase 3 ABRAXANE(R) Combination Trial In First-Line Non-Small Cell Lung Cancer Show 31 Percent Improvement In Response Rate Compared With Taxol Combination
June 7, 2010
 · 
1 min read
Drug Development
Allos Therapeutics, Inc. Reports New Data Demonstrating that Responses to FOLOTYN are Correlated with Prolonged Survival in Patients with Relapsed or Refractory PTCL
June 7, 2010
 · 
1 min read
Drug Development
Celgene International Sárl Release: Randomized Phase III Study Comparing REVLIMID(R) Plus Melphalan and Prednisone (MPR) Compared to Autologous Stem Cell Transplant Presented at American Society of Clinical Oncology
June 7, 2010
 · 
1 min read
Drug Development
At American Society of Clinical Oncology, Oral Presentation from Intergroupe Francophone Du Myelome (IFM) of Phase III Study (IFM 2005 02) Evaluating Continuous REVLIMID® in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant
June 7, 2010
 · 
1 min read
Drug Development
Millennium: The Takeda Oncology Company Release: Oral Presentations Showcase Impressive Results of VELCADE(R) (bortezomib) Based Therapy in Multiple Myeloma
June 7, 2010
 · 
1 min read
Drug Development
Adding Novartis Corporation Drug Zometa(R) to Chemotherapy Significantly Improved Overall Survival in Study of Newly Diagnosed Multiple Myeloma Patients
June 7, 2010
 · 
13 min read
Drug Development
Eli Lilly and Company, Merck KGaA Erbitux Fails to Stop Colon Cancer Before It Spreads
June 7, 2010
 · 
1 min read
Load More